Institutional investors control 74 percent of The Chemours Company and were rewarded last week after stock increased 5.7 percent - Simply Wall St
SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Under 61% of Syneos Health's investor base is looking to short. The analysis of current outlook of investing in Syneos Health suggests that many traders are alarmed regarding Syneos Health's prospects. Syneos Health's investing sentiment shows overall attitude of investors towards Syneos Health.
Syneos |
Institutional investors control 74 percent of The Chemours Company and were rewarded last week after stock increased 5.7 Simply Wall St
Read at news.google.com
Syneos Health Fundamental Analysis
We analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Syneos Health is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Syneos Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syneos Health stock to make a market-neutral strategy. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics with similar companies.
Peers
Syneos Health Related Equities
MEDP | Medpace Holdings | 1.74 | ||||
SHC | Sotera Health | 1.06 | ||||
MTD | Mettler Toledo | 0.50 | ||||
CRL | Charles River | 0.37 | ||||
QGEN | Qiagen NV | 0.20 | ||||
MYGN | Myriad Genetics | 0.07 | ||||
IQV | IQVIA Holdings | 0.35 | ||||
LH | Laboratory | 0.64 | ||||
ICLR | ICON PLC | 0.65 | ||||
NEOG | Neogen | 1.65 | ||||
ACRS | Aclaris Therapeutics | 2.48 | ||||
RDNT | RadNet | 2.64 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |